Clozapine for Management of Neuropsychiatric Symptoms in Dementia with Lewy Bodies: Case Report and Literature Review.

Nikoo Hashemi, Dean Yang, David Shergold, Gayla Tennen, Chris Fan-Lun

Open access · bronzeAbstract readCase Reports

In one paragraph

Article in The Canadian journal of hospital pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

1.0field-weighted citation impact, top 22% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

Clozapine Mitigates Lipopolysaccharide-Induced Cognitive Dysfunction by Modulating Cholinergic Function, Oxidative Stress, and Apoptotic Signaling in Rats.Life (Basel, Switzerland) · 2026
Article
Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders.Movement disorders clinical practice · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nikoo Hashemi, BSc, MSc, PharmD, was, at the time this manuscript was prepared a PharmD candidate with the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario. She has now graduated.

Dean Yang, BScPhm, BCGP, is a staff pharmacist with the Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Ontario.

David Shergold, MD, is a staff physician with the Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario.

Gayla Tennen, MD, FRCPC, is a Lecturer with the Department of Psychiatry, University of Toronto, and a staff psychiatrist with the Department of Clinical Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario.

Chris Fan-Lun, BScPhm, ACPR, BCGP, is an Adjunct Lecturer with the Leslie Dan Faculty of Pharmacy, University of Toronto, and is a Clinical Coordinator with the Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Ontario.

Sunnybrook Health Science Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37767388

DOI10.4212/cjhp.3390

PMCPMC10522355

OpenAlexW4387116157

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.